-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Initiates Coverage On 10x Genomics with Buy Rating, Announces Price Target of $110

Benzinga·09/28/2026 12:12:05
Diffusion vocale
Argus Research analyst John Eade initiates coverage on 10x Genomics (NASDAQ:TXG) with a Buy rating and announces Price Target of $110.